UNH has built up a head of steam for an upside breakout.
Let's check out the charts of this health technology company.
Opko's BioReference Laboratories is on the cutting edge of Covid-19 testing.
Long-time investors in JNJ are probably not surprised how well the stock has responded in the past few weeks.
There are plenty of good reasons to invest in JNJ, but one resonates with me more than any other.
Shares of the maker of robotic surgery systems have rallied after a sharp drop, so a pullback could be in order before the uptrend resumes.
With a strong history in an important industry, Becton Dickinson looks set to provide and increase its dividend through this crisis and beyond.
Several companies that had appeared promising are now blaming the Covid-19 crisis as they fail to turn over a new leaf for the better.
UNH has moved up strongly from its March nadir so traders and investors should approach from the long side.
Focus on coronavirus patients has hospitals deferring elective surgeries, but eventually patients who need knee, hip and other replacements will be back on surgical schedules.